Skip to content

Analgesia after Infiltration at the removal site of the graft of the flexor tendons in Anterior Cruciate Ligament Reconstruction

Analgesia in Multimodal Infiltration of the donor site of flexor tendons in Anterior Cruciate Ligament Reconstruction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-2g3hpyc
Enrollment
Unknown
Registered
2023-11-01
Start date
2022-11-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain

Interventions

A prospective, randomized, triple-blind study will be carried out The eligible study population will consist of patients approved for anterior cruciate ligament ACL reconstruction at the Hospital Nava
so that group A will receive a solution of ropivacaine with 20 milliliters (0.75%), clonidine 150 micrograms/milliliter (0.5 milliliters), ketorolac 30 milligrams/milliliter (1 milliliter) and adrenal
group B will receive ropivacaine 20 milliliters (0.75%) and tr
E03.155.086.231
E01.370.600.550.324
A01.935

Sponsors

Clínica de Traumato-Ortopedia do Hospital Naval Marcílio Dias
Lead Sponsor
Clínica de Traumato-Ortopedia do Hospital Naval Marcílio Dias
Collaborator

Eligibility

Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Participants who underwent Anterior Cruciate Reconstruction ACL reconstruction with grafts from the flexor tendons; of both sexes; aged between 18 and 50 years will be included

Exclusion criteria

Exclusion criteria: Patients submitted to revision of Anterior Cruciate Ligament ACL reconstruction, Anterior Cruciate Ligament ACL reconstruction using other grafts; submitted to multiligamentous reconstruction; valgus osteotomy of the tibia or concomitant cartilage repair procedure; allergy to any of the drugs; in chronic use of analgesics; with Body Mass Index BMI above 35 kg/m2 and patients with a history of previous knee surgery

Design outcomes

Primary

MeasureTime frame
it is expected to find a decrease in postoperative pain with the association of adjuvant drugs with local anesthetics by a difference of at least two points based on the method of evaluation of the visual analogue pain scale in the initial 24 hours of surgery in the hospital environment and in the next 6 days in the extra-hospital environment.

Secondary

MeasureTime frame
It is expected to find a lower consumption of opioids by the method of evaluating the consumption in grams in the medical prescription of the drug in the hospital and extra-hospital environment.;It is expected to find a better range of motion after 24 hours of surgery and 7 days after surgery using the method of evaluating passive knee extension and flexion using a goniometer measuring degrees.

Countries

Brazil

Contacts

Public ContactPedro Matos

Hospital Naval Marcílio Dias

pedro_acmatos@hotmail.com+55(21)2599-5416

Outcome results

None listed

Source: REBEC (via WHO ICTRP)